AIM: To examine, in a national survey, the outcomes of adult @entity1 presenting with @entity6 in 2014, mapped against accepted UK national guidance. METHODS: Data were collected in a standardized form covering clinical and biochemical outcomes, risk and discharge planning. The form was sent to all UK @entity6 specialist teams (n = 220). Anonymized data were collected on five consecutive @entity1 admitted with @entity6 between 1 May 2014 and 30 November 2014. RESULTS: A total of 283 forms were received (n = 281 @entity1 ) from 72 hospitals, of which 71.4% used the national guidelines. The results showed that 7.8% of cases occurred in existing inpatients, 6.1% of admissions were newly diagnosed @entity6 and 33.7% of @entity1 had had at least one episode of @entity6 in the preceding year. The median times to starting 0.9% @entity2827 and intravenous insulin were 41.5 and 60 min, respectively. The median time to resolution was 18.7 h and the median length of hospital stay was 2.6 days. Significant adverse biochemical outcomes occurred, with 27.6% of @entity1 developing hypoglycaemia and 55% reported as having hypokalaemia. There were also significant issues with care processes. Initial nurse-led observations were carried out well, but subsequent @entity1 monitoring remained suboptimal. Most @entity1 were not seen by a member of the @entity6 specialist team during the first 6 h, but 95% were seen before discharge. A significant minority of discharge letters to primary care did not contain necessary information. CONCLUSION: Despite widespread adoption of national guidance, several areas of management of @entity6 are suboptimal, being associated with avoidable biochemical and clinical risk.

National survey of the management of XXXX ( @entity6 ) in the UK in 2014.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity2827 :: ('MESH:D012965', 'Chemical') :: ['sodium chloride'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes', 'DKA']
@entity6 :: (MESH:D003920,Disease) :: ['Diabetic Ketoacidosis']
